PROSTATE CANCER THERAPEUTICS MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024 - 2031)

Table of Contents (Version-2026)

1. Research Objective and Assumption

• Research Objectives
• Assumptions
• Abbreviations

2. Market Overview

• Report Description
• Market Definition and Scope
• Executive Summary
• Market Snippet, By Drug Type
• Market Snippet, By Distribution Channel
• Market Snippet, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
• Drivers
• Restraints
• Market Opportunities
• Impact Analysis
• Regulatory Scenario
• Reimbursement Scenario
• Pipeline Analysis
• PEST Analysis
• PORTER’S Five Forces

4. Global Prostate Cancer Therapeutics Market, By Drug Type, 2017 - 2025, (US$ Million)

• Introduction
• Market Share Analysis, 2016 and 2025 (%)
• Y-o-Y Growth Analysis, 2017 - 2025
• Segment Trends
• Hormonal Therapy
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
  • Luteinizing Hormone-Releasing Hormone (LHRH) Antagonist
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
      • Abiraterone Acetate (Zytiga)
        • Introduction
        • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
      • Degarelix Acetate (Firmagon/Gonax)
        • Introduction
        • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
  • Luteinizing Hormone-Releasing Hormone (LHRH) Agonist
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
      • Goserelin Acetate (Zoladex)
        • Introduction
        • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
      • Leuprorelin Acetate (Prostap or Lutrate)
        • Introduction
        • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
      • Triptorelin (Trelstar)
        • Introduction
        • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
      • Others
        • Introduction
        • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
• Anti-Androgens
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
    • Enzalutamide (Xtandi)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
    • Nilutamide (Nilandron)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
    •  Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
• Immunotherapy
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
    • Sipuleucel-T (Provenge)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
• Targeted Therapy
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
    • Radium 223 Dichloride (Xofigo)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
• Chemotherapy
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
    • Cabazitaxel (Jevtana)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
    • Docetaxel (Taxotere)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)

5. Global Prostate Cancer Therapeutics Market, By Distribution Channel, 2017 - 2025, (US$ Million)

   • Introduction
     • Market Share Analysis, 2016 and 2025 (%)
     • Y-o-Y Growth Analysis, 2017 - 2025
     • Segment Trends
   • Hospital Pharmacies
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
   • Retail Pharmacies
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
   • Online Pharmacies
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)

6. Global Prostate Cancer Therapeutics Market, By Region, 2017 - 2025, (US$ Million)

   • Introduction
     • Market Share Analysis, By Region, 2016 and 2025 (%)
     • Y-o-Y Growth Analysis, By Region, 2017 - 2025
   • North America
     • Market Size and Forecast, By Drug Type, 2017 - 2025, (US$ Million)
     • Market Size and Forecast, By Distribution Channel, 2017 - 2025, (US$ Million)
     • Market Size and Forecast, By Country, 2017 - 2025, (US$ Million)
       • U.S.
• Canada
• Europe
• Market Size and Forecast, By Drug Type, 2017 - 2025, (US$ Million)
• Market Size and Forecast, By Distribution Channel, 2017 - 2025, (US$ Million)
• Market Size and Forecast, By Country, 2017 - 2025, (US$ Million)
• U.K.
• Germany
• Italy
• France
• Spain
• Russia
• Rest of Europe
• Asia Pacific
• Market Size and Forecast, By Drug Type, 2017 - 2025, (US$ Million)
• Market Size and Forecast, By Distribution Channel, 2017 - 2025, (US$ Million)
• Market Size and Forecast, By Country, 2017 - 2025, (US$ Million)
• China
• Japan
• India
• ASEAN
• Australia
• South Korea
• Rest of Asia Pacific
• Latin America
• Market Size and Forecast, By Drug Type, 2017 - 2025, (US$ Million)
• Market Size and Forecast, By Distribution Channel, 2017 - 2025, (US$ Million)
• Market Size and Forecast, By Country, 2017 - 2025, (US$ Million)
• Brazil
• Mexico
• Rest of Latin America
• Africa
• Market Size and Forecast, By Drug Type, 2017 - 2025, (US$ Million)
• Market Size and Forecast, By Distribution Channel, 2017 - 2025, (US$ Million)
• Market Size and Forecast, By Country, 2017 - 2025, (US$ Million)
• Northern Africa
• Central Africa
• South Africa
• Middle East
• Market Size and Forecast, By Drug Type, 2017 - 2025, (US$ Million)
• Market Size and Forecast, By Distribution Channel, 2017 - 2025, (US$ Million)
• Market Size and Forecast, By Country, 2017 - 2025, (US$ Million)
• GCC Countries
• Israel
• Rest of Middle East
7. Competitive Landscape
• Heat Map Analysis
• Company Profiles
• Johnson & Johnson
• Company Overview
• Technology Portfolio
• Financial Performance
• Recent Developments/Updates
• Strategies
• Astellas Pharma, Inc
• Company Overview
• Technology Portfolio
• Financial Performance
• Recent Developments/Updates
• Strategies
• Sanofi
• Company Overview
• Technology Portfolio
• Financial Performance
• Recent Developments/Updates
• Strategies
• Bayer AG
• Company Overview
• Technology Portfolio
• Financial Performance
• Recent Developments/Updates
• Strategies
• AstraZeneca Plc
• Company Overview
• Technology Portfolio
• Financial Performance
• Recent Developments/Updates
• Strategies
• Pfizer, Inc.
• Company Overview
• Technology Portfolio
• Financial Performance
• Recent Developments/Updates
• Strategies
• Dendreon Corporation (Sanpower Group Co. Ltd.)
• Company Overview
• Technology Portfolio
• Financial Performance
• Recent Developments/Updates
• Strategies
• Ipsen Group
• Company Overview
• Technology Portfolio
• Financial Performance
• Recent Developments/Updates
• Strategies
• Tolmar Inc
• Company Overview
• Technology Portfolio
• Financial Performance
• Recent Developments/Updates
• Strategies
• Endo International plc
• Company Overview
• Technology Portfolio
• Financial Performance
• Recent Developments/Updates
• Strategies
• AbbVie, Inc.
• Company Overview
• Technology Portfolio
• Financial Performance
• Recent Developments/Updates
• Strategies

8. Section

• Analyst Views
• Research Methodology
• About Us and Sales Contact

*Browse 29 market data tables and 33 figures on "Prostate Cancer Therapeutics Market - Global forecast to 2025”.